| RS1433703349 |
RFWD3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143370662 |
HGD
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkaptonuria, Alkaptonuria |
| RS143370729 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 29 |
| RS143371162 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143371620 |
AGMO
|
Health Risk |
Conflicting classifications of pathogenicity |
AGMO-related disorder, AGMO-related disorder |
| RS143371801 |
FAM20A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433723046 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS143372639 |
GEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143372872 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS143373007 |
POU1F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS1433745760 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1433746078 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1433746199 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1433760506 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Gastrointestinal stromal tumor |
| RS143377172 |
TBX19
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS143377309 |
IL11RA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143378216 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS1433783398 |
EIF2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433783445 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS143378690 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS143378852 |
TK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, myopathic form |
| RS1433795312 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1433806086 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS143380907 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS1433816476 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS143381873 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433820460 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143382568 |
ARVCF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143382715 |
CAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143383382 |
ARSL
|
Health Risk |
Likely pathogenic |
— |
| RS1433852047 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1433859526 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS143386224 |
CYP19A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aromatase deficiency, Aromatase deficiency |
| RS1433862850 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS143386487 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMA5-related disorder |
| RS1433866863 |
HSPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 13, Spastic paraplegia |
| RS143386746 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1433868678 |
GRM6
|
Health Risk |
Pathogenic |
— |
| RS1433868957 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS143388122 |
PIEZO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143388292 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS143388851 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS143388949 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1433893010 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1433893346 |
ATP2A1
|
Health Risk |
Pathogenic |
Brody myopathy, Brody myopathy |
| RS143389426 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143389605 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS143389941 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS143391593 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS143392665 |
ATP11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143393026 |
CARD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS143393049 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143393575 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Distal myopathy with anterior tibial onset |
| RS143393771 |
ZNF423
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 14, Tibial muscular dystrophy |
| RS143393884 |
GANAB
|
Health Risk |
Conflicting classifications of pathogenicity |
GANAB-related disorder, GANAB-related disorder |
| RS143394031 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS143394182 |
POMGNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS143395134 |
MC1R
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Skin and Hair Hypopigmentation |
| RS1433952909 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Inborn genetic diseases |
| RS143396225 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS143396390 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS1433965473 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1433969585 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS143396975 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS143397183 |
C2CD3
|
Health Risk |
Pathogenic |
— |
| RS1433972399 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS143397927 |
PKP2
|
Health Risk |
Likely pathogenic |
— |
| RS143399084 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL17A1-related disorder |
| RS1433991680 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS143399744 |
KCNQ2
|
Health Risk |
Pathogenic |
KCNQ2-related disorder, Early-infantile DEE |
| RS1434008042 |
PKLR
|
Health Risk |
Pathogenic |
— |
| RS1434010689 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS143401208 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS1434021544 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS143402711 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia 1, Sitosterolemia |
| RS1434042239 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1434051128 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS143405115 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS143405567 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia, Citrullinemia |
| RS143406017 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS143406263 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Polydactyly, postaxial |
| RS1434065199 |
KMT5B
|
Health Risk |
Pathogenic |
— |
| RS1434069831 |
FANCD2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group D2, FANCD2-related disorder |
| RS1434072252 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS143407309 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS143408155 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS1434100445 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS143410219 |
CASP8
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 2B, Autoimmune lymphoproliferative syndrome type 2B |
| RS1434102843 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS143410330 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143410470 |
ANLN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1434109608 |
RAG2
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS143411142 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, COG8-related disorder |
| RS143411357 |
COQ8B
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 9 |
| RS1434118781 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1434118877 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS143412169 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 13A (Zellweger), Peroxisome biogenesis disorder |
| RS143412184 |
IL17RC
|
Health Risk |
Conflicting classifications of pathogenicity |
Candidiasis, familial |
| RS1434123349 |
TBX20
|
Health Risk |
Pathogenic |
— |
| RS143413500 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Inborn genetic diseases |